Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
28.63
+0.28 (0.99%)
At close: Mar 6, 2026, 4:00 PM EST
28.12
-0.51 (-1.78%)
After-hours: Mar 6, 2026, 7:29 PM EST
Alkermes Market Cap
Alkermes has a market cap or net worth of $4.77 billion as of March 6, 2026. Its market cap has decreased by -18.13% in one year.
Market Cap
4.77B
Enterprise Value
4.25B
1-Year Change
-18.13%
Ranking
Category
Stock Price
$28.63
Market Cap Chart
Since December 1, 1998, Alkermes's market cap has increased from $383.70M to $4.77B, an increase of 1,143.47%. That is a compound annual growth rate of 9.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 4.72B | 2.26% |
| Dec 31, 2025 | 4.62B | -0.72% |
| Dec 31, 2024 | 4.65B | 0.52% |
| Dec 29, 2023 | 4.63B | 7.82% |
| Dec 30, 2022 | 4.29B | 14.15% |
| Dec 31, 2021 | 3.76B | 18.47% |
| Dec 31, 2020 | 3.18B | -1.20% |
| Dec 31, 2019 | 3.21B | -29.92% |
| Dec 31, 2018 | 4.59B | -45.52% |
| Dec 29, 2017 | 8.42B | -0.36% |
| Dec 30, 2016 | 8.45B | -29.09% |
| Dec 31, 2015 | 11.91B | 39.10% |
| Dec 31, 2014 | 8.56B | 53.99% |
| Dec 31, 2013 | 5.56B | 127.59% |
| Dec 31, 2012 | 2.44B | 8.61% |
| Dec 30, 2011 | 2.25B | 91.59% |
| Dec 31, 2010 | 1.17B | 31.68% |
| Dec 31, 2009 | 891.70M | -12.16% |
| Dec 31, 2008 | 1.02B | -36.29% |
| Dec 31, 2007 | 1.59B | 18.17% |
| Dec 29, 2006 | 1.35B | -22.92% |
| Dec 30, 2005 | 1.75B | 37.76% |
| Dec 31, 2004 | 1.27B | 5.23% |
| Dec 31, 2003 | 1.21B | 197.29% |
| Dec 31, 2002 | 405.90M | -76.06% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regencell Bioscience Holdings | 11.55B |
| Lantheus Holdings | 4.69B |
| Amneal Pharmaceuticals | 4.17B |
| Hims & Hers Health | 3.59B |
| Kiniksa Pharmaceuticals International, | 3.53B |
| Prestige Consumer Healthcare | 3.18B |
| Liquidia | 3.17B |
| Supernus Pharmaceuticals | 3.10B |